LetterInfluence of β2-adrenoceptor 16 genotype on propranolol-induced bronchoconstriction in patients with persistent asthma
References (6)
- et al.
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Lancet
(2004) - et al.
Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol
J Allergy Clin Immunol
(2009) - et al.
Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics
Lancet
(1997)
There are more references available in the full text version of this article.
Cited by (4)
Of mice and men-the curious tale of β blockers in asthma
2016, The Lancet Respiratory MedicineYear in review: Basic science
2015, Annals of Allergy, Asthma and ImmunologyBeta-blockers in COPD: Time for reappraisal
2016, European Respiratory Journal
Trial Registration: clinicaltrials.gov Identifiers: NCT01544634 and NCT01074853.
Disclosures: Authors have nothing to disclose.
Funding: This study was funded by Chief Scientist Office for Scotland project grant CZB/4/716.
Copyright © 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.